[
    [
        {
            "time": "",
            "original_text": "生物医药板块全线大涨，两条主线布局投资机会（附股）丨牛熊眼",
            "features": {
                "keywords": [
                    "生物医药",
                    "全线大涨",
                    "投资机会"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "生物医药板块全线大涨，两条主线布局投资机会（附股）丨牛熊眼",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药板块强势拉升，仿制药类股表现亮眼，华海药业等涨停",
            "features": {
                "keywords": [
                    "医药板块",
                    "强势拉升",
                    "仿制药",
                    "华海药业",
                    "涨停"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "仿制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药板块强势拉升，仿制药类股表现亮眼，华海药业等涨停",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "2020年A股医药行业年报盘点：被集采深度改写了业绩报表 药品脱敏药械进入深水区",
            "features": {
                "keywords": [
                    "2020年",
                    "A股",
                    "医药行业",
                    "年报",
                    "集采",
                    "业绩报表",
                    "药品脱敏",
                    "药械",
                    "深水区"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "药械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2020年A股医药行业年报盘点：被集采深度改写了业绩报表 药品脱敏药械进入深水区",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]